Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
EARLY_PHASE1
46 participants
INTERVENTIONAL
2012-12-31
2013-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exercise Training and Plasma Lipoproteins in Man
NCT00000519
Optimal Exercise Regimens for Persons at Increased Risk
NCT00000523
Exercise Intervention on Cardiorespiratory Function in HF With DM.
NCT04888390
Effect of Aerobic Exercise Training in Obese Adults
NCT05202535
Dose Response to Exercise and Cardiovascular Health
NCT00005555
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
experimental 1
men with exercise training for 3 months
exercise training
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
exercise training
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 18-25 years
* body mass index (BMI) 18-25 kg/m2
* no regular exercise
* no tobacco use
* no current use of prescribed medications
* no self-report of acute of chronic diseases
18 Years
22 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
No. 150 Central Hospital of the Chinese People Liberation Army
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shenxu Wang, MD
Role: STUDY_DIRECTOR
No. 150 Central Hospital of PLA
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
No. 150 Central hospital of Chinese People's Liberation Army
Luoyang, Henan, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
150CTSX002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.